Tenax Therapeutics Financial Overview
Tenax Therapeutics's market cap is currently $69.68M. The company's EPS TTM is $-0.4; its P/E ratio is -10.40; Tenax Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
